uniQure N.V.

NASDAQ:QURE

uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases.

uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

The Conversation (0)
MARKETS
COMMODITIES
CURRENCIES